JnJ keeps vaccine sales outlook unchanged after Q3 miss Ruchika Sharma20 Oct 2021 12:54 PM ISTNew Delhi: Johnson & Johnson on Tuesday reported lower-than- expected quarterly revenue after sales of its COVID-19 vaccine missed Wall...
USFDA panel mulls mixing, matching Covid-19 vaccine doses MD Bureau20 Oct 2021 10:00 AM ISTWashington: After endorsing both Moderna and Johnson & Johnson's Covid booster doses last week, the US Food and Drug Administration is now...
Patients below 40 more likely to recover from COVID related smell, taste loss Dr. Nandita Mohan19 Oct 2021 3:15 PM ISTSense of smell or taste returns within six months for 4 out of every 5 COVID-19 survivors who have lost these senses, and those under 40 are more...
Potential presence of carcinogen: Lupin recalls Irbesartan, Irbesartan & Hydrochlorothiazide tablets Medical Dialogues Team19 Oct 2021 2:18 PM ISTNew Delhi: The US subsidiary Lupin Pharmaceuticals Inc is voluntarily recalling the batches of popular antihypertensive medicines Irbesartan Tablets...
Oyster Point Pharma secures USFDA approval for TYRVAYA nasal spray to treat dry eye disease Ruchika Sharma19 Oct 2021 1:01 PM ISTEach nasal spray bottle covers treatment for 15 days, administered twice daily into each nostril.
Dr Reddy's Labs bags USFDA okay for Lenalidomide capsules Ruchika Sharma19 Oct 2021 11:45 AM ISTHyderabad: Drugmaker, Dr. Reddy's Laboratories Ltd., today announced the final approval of its Abbreviated New Drug Application (ANDA) for ...
Granules India arm gets USFDA nod for Dofetilide capsules Ruchika Sharma19 Oct 2021 11:19 AM ISTDofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm.
WHO-led program aims to purchase antiviral COVID pills for USD 10 Ruchika Sharma19 Oct 2021 10:00 AM ISTBrussels: A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to...
Merck COVID-19 drug sparks calls for access for lower income countries Ruchika Sharma18 Oct 2021 3:38 PM ISTNew Delhi: The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution,...
Exelixis in-licenses 2nd anti-cancer compound from Aurigene Ruchika Sharma18 Oct 2021 1:27 PM ISTAlameda: Exelixis, Inc. and Aurigene Discovery Technologies Limited have announced that Exelixis has exercised its exclusive option under the...
WHO technical advisory group to discuss Covaxin EUL on October 26 Ruchika Sharma18 Oct 2021 1:06 PM ISTHyderabad: The technical advisory group of the World Health Organisation (WHO) will meet on October 26 to consider emergency use listing for Bharat...
Despite ALS drug trial failing main goal, Biogen says data are encouraging Ruchika Sharma18 Oct 2021 1:02 PM ISTNew Delhi: A late-stage trial of Biogen Inc's experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its...
